VETOF (Vetoquinol) Ending Cash Position: $258.7 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

VETOF Vetoquinol SA VETOF
94 GF Score
Price $90.80
GF Value $108.39
! 1 Warning Sign
View Full Analysis

What is Vetoquinol Ending Cash Position?

Vetoquinol VETOF 94 Ending Cash Position is $258.7 Mil as of Dec. 2025. GuruFocus rates VETOF with a GF Score™ of 94/100 and a GF Value™ of $108.39. The stock has 1 warning sign investors should review.

Vetoquinol's Ending Cash Position for the quarter that ended in Dec. 2025 was $258.7 Mil.

Vetoquinol's quarterly Ending Cash Position declined from Dec. 2024 ($212.0 Mil) to Jun. 2025 ($207.6 Mil) but then increased from Jun. 2025 ($207.6 Mil) to Dec. 2025 ($258.7 Mil).

Vetoquinol's annual Ending Cash Position increased from Dec. 2023 ($159.4 Mil) to Dec. 2024 ($212.0 Mil) and increased from Dec. 2024 ($212.0 Mil) to Dec. 2025 ($258.7 Mil).

Vetoquinol Ending Cash Position Related Terms

Vetoquinol Ending Cash Position Historical Data

* Premium members only.

The historical data trend for Vetoquinol's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vetoquinol Ending Cash Position Chart

Vetoquinol Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 76.96 99.14 159.44 211.98 258.73

Vetoquinol Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 159.44 169.07 211.98 207.56 258.73
VETOF
94GF Score
Vetoquinol SA VETOF
Ending Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vetoquinol Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Vetoquinol's Ending Cash Position for the fiscal year that ended in Dec. 2025 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=237.045+21.681
=258.7

Vetoquinol's Ending Cash Position for the quarter that ended in Dec. 2025 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=210.716+48.01
=258.7

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of $258.7 Mil mean?
Vetoquinol (VETOF) has a Ending Cash Position of $258.7 Mil as of Dec. 2025. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Vetoquinol and its competitors.
Is Vetoquinol's Ending Cash Position too high?
Vetoquinol's current Ending Cash Position is $258.7 Mil. Overall, Vetoquinol has a GF Score™ of 94/100, reflecting its overall financial health beyond just this single metric.
How does Vetoquinol's Ending Cash Position compare to ZTS and UTHR?
Vetoquinol's Ending Cash Position of $258.7 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Drug Manufacturers company?
A good Ending Cash Position depends on the Drug Manufacturers industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Vetoquinol and its competitors. Vetoquinol's current Ending Cash Position is $258.7 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vetoquinol stock overvalued right now?
Vetoquinol (VETOF) has a current Ending Cash Position of $258.7 Mil. The stock's GF Value™ is $108.39, compared to a current price of $90.80 — trading 16.2% below its estimated fair value. The current Ending Cash Position is $258.7 Mil. Vetoquinol's overall GF Score™ is 94/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For Vetoquinol (VETOF), the current Ending Cash Position is $258.7 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Vetoquinol (VETOF) Overvalued in 2026?

Based on GuruFocus' analysis, Vetoquinol stock appears to be undervalued. The current stock price of $90.80 is trading 16.2% below its estimated GF Value™ of $108.39.

Key valuation signals for VETOF:

  • Ending Cash Position: $258.7 Mil
  • GF Value™: $108.39 vs. price of $90.80 (16.2% below fair value)
  • GF Score™: 94/100 with 1 warning sign

No single metric tells the full story. See the VETOF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Vetoquinol Business Description

Address Magny-Vernois, BP 189, Lure cedex, FRA, 70204
Vetoquinol SA operates is a France-based firm serving in the healthcare market. Its focus lies on developing and marketing veterinary drugs mainly in the European region and to a certain extent in America and Asia. Its portfolio of drugs entails anti-infectives, anti- pain inflammatory drugs, cardiovascular and nephrology treatment intended mainly for pets and livestock.
94GF Score

Get the complete analysis for VETOF

Ending Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$90.80
Price
$108.39
GF Value